The enhanced number of infiltrated CD45+ leukocytes in Abcb4-/- mice was abolished by rimonabant, which indicates an anti-inflammatory effect of pharmacologic CB1 antagonization during cholestasis. This evidence concerns the gene PTPRC and cholestasis.